# Ozempic Maker Testifies Before Senate Committee on Weight-Loss Drug Prices ## Key Points: – Novo Nordisk, the maker of Ozempic, testified before the Senate Committee on Finance about the pricing of weight-loss drugs. – The focus was on ensuring affordable access to medications that can help combat obesity. – Novo Nordisk highlighted the importance of promoting healthy lifestyles alongside medication use. – The Senate Committee aimed to address concerns about the affordability of weight-loss drugs for patients. Novo Nordisk’s testimony before the Senate Committee underscores the commitment to making weight-loss medications accessible to those in need. By addressing concerns about drug pricing and advocating for healthy lifestyle choices, they are contributing to the collective effort to combat obesity. It is crucial to continue discussions and actions that promote affordable access to effective weight-loss treatments. Contact Mindful Evolution on our website at https://yourmindfulevolution.com or call or text us at 954-639-9960 to explore personalized weight-loss solutions through telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Weight Loss Disclaimer: Results may vary. Proper diet and exercise are necessary to achieve and maintain weight loss.